NCPI
NIH Cloud PlatformInteroperability Effort
searchclose
YouYube

Study

arrow_backDatasets

NHLBI TOPMed: Study of African Americans, Asthma, Genes and Environment (SAGE)

phs000921.v4.p1dbGapdbGap FHIR

Description

This is a parallel case-control pharmacogenetic study of bronchodilator drug response among African American children with and without asthma. Each participant had spirometry measured using the KoKo PFT System. Asthmatic participants were administered with 4 puffs of HFA Albuterol. Healthy participants were given a baseline spirometry test. The overall goal is to identify genetic factors which are predictive of drug response in children with asthma. The principal tools include a questionnaire and biological specimen collection. Participants were 8-21 years old at time of recruitment. Children with asthma have physician-diagnosed asthma, symptoms and medications.

Summary

PlatformsBDC
Consent CodesDS-LD-IRB-COL
Focus / DiseasesLung Diseases
Study DesignCase-Control
Data TypesSNP/CNV Genotypes (NGS), WGS
Subjects2,106